Fosgonimeton, an experimental therapy Athira Pharma is developing to treat Alzheimer’s disease, was well-tolerated overall in a Phase 1 clinical trial that included Alzheimer’s patients as well as healthy volunteers. “These encouraging results showed a positive safety and tolerability profile of fosgonimeton across a wide dose range,” Hans Moebius, MD, PhD, Athira’s chief medical officer, said in a press […]

A number of pharmaceutical companies have recently revealed changes to their CEO roles, but other leadership team members have also been announced. BioSpce takes a look at this week’s Movers & Shakers. Ribon Therapeutics – Prakesh Raman was named president and chief executive officer, succeeding Victoria Richon in these roles. Prior to joining Ribon, Raman served […]

Enduring partnerships take effort; they take strong communication and a vision for a future that will outlast even the participants. While match-making sites obsess over finding commonalities, often the best partnerships are built on complementary qualities and skillsets. Take Kyowa Kirin Pharmaceutical Research, Inc. and La Jolla Institute for Immunology (LJI), for example. The New Jersey-based specialty pharmaceutical company […]